Dr. Kyle Robert Sweeney, MD

Dr. Sweeney practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Sweeney's NPI, 1013208305, was assigned on April 21, 2011. Dr. Sweeney graduated from Vanderbilt University School of Medicine in 2007. Dr. Sweeney holds Illinois license 036139762.

Dr. Sweeney's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Sweeney's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Sweeney is also affiliated with AdventHealth Shawnee Mission. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Sweeney to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sweeney practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Sweeney's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Sweeney is licensed in Illinois.

CMS data shows 411 Medicare services from Dr. Sweeney across 9 procedure codes in 2024, for 320 Medicare patients. Medicare paid $47,445 for them.

CMS counts 320 Medicare patients who saw Dr. Sweeney in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sweeney's median patient age at 67, with 57% women.

In 2024, Dr. Sweeney wrote 75 Medicare Part D claims for 51 patients. 96% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $103 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sweeney for performance year 2024, reported through an alternative payment model (APM). Dr. Sweeney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sweeney as offering telehealth. CMS counts 23 procedures of melanoma (skin cancer) excision by Dr. Sweeney, more than 76% of the clinicians it reports for that procedure.

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Sweeney, published from 2020 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Bone Neoplasms, Antifibrinolytic Agents and Tranexamic Acid. Dr. Sweeney has published most often in J Surg Oncol. Dr. Sweeney's most frequent co-authors are Douglas Reed Haase, MD, Alan T. Blank, MD and Matthew Wesley Colman, MD.

Dmand AI links Dr. Sweeney to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Giant Cell Tumor of Bone, Sarcoma and Giant Cell Tumors.

CMS Open Payments shows 213 general payments to Dr. Sweeney from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Stryker Corporation paid the most, $4,623.

Dr. Sweeney graduated from Vanderbilt University School of Medicine in 2007.